Try our Advanced Search for more refined results
June 13, 2023
Pharmacyclics LLC v. BeiGene USA, Inc. et al
Case Number:
1:23-cv-00646
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
June 15, 2023
AbbVie Unit Launches Patent Suit Over Cancer Drug
AbbVie's Pharmacyclics unit has alleged in a new suit that its recently issued patent relating to its cancer drug Imbruvica is being infringed by a BeiGene product that got approval from federal regulators earlier this year.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login